Page last updated: 2024-10-21
5,5-dimethyl-1-pyrroline-1-oxide and Atherosclerotic Parkinsonism
5,5-dimethyl-1-pyrroline-1-oxide has been researched along with Atherosclerotic Parkinsonism in 1 studies
5,5-dimethyl-1-pyrroline-1-oxide: do not confuse with DMPO (4',5'-dihydroxy-7-methoxy-4-phenyl-5,2'-oxidocoumarin)
5,5-dimethyl-1-pyrroline N-oxide : A member of the class of 1-pyrroline nitrones (1-pyrroline N-oxides) resulting from the formal N-oxidation of 5,5-dimethyl-1-pyrroline. Used as a spin trap for the study of radicals formed by enzymatic acetaldehyde oxidation.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Zang, LY | 1 |
Misra, HP | 1 |
Other Studies
1 other study available for 5,5-dimethyl-1-pyrroline-1-oxide and Atherosclerotic Parkinsonism
Article | Year |
---|---|
EPR kinetic studies of superoxide radicals generated during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium, a bioactivated intermediate of parkinsonian-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; | 1992 |